BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31500350)

  • 1. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
    Klener P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
    Nastoupil LJ; Koff JL; Flowers CR
    Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Dreyling M
    Hematol Oncol; 2021 Jun; 39 Suppl 1():31-38. PubMed ID: 34105823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology.
    Tang T; Martin P
    Curr Hematol Malig Rep; 2014 Sep; 9(3):254-61. PubMed ID: 25023397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular pathogenesis of mantle cell lymphoma.
    Vogt N; Dai B; Erdmann T; Berdel WE; Lenz G
    Leuk Lymphoma; 2017 Jul; 58(7):1530-1537. PubMed ID: 27894215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma-management in evolution.
    Rajguru S; Kahl BS
    Chin Clin Oncol; 2015 Mar; 4(1):8. PubMed ID: 25841715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?
    El Halabi L; Ghez D; Ribrag V
    Expert Rev Hematol; 2016 Mar; 9(3):271-81. PubMed ID: 26689790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment.
    Papin A; Le Gouill S; Chiron D
    Leuk Lymphoma; 2018 May; 59(5):1064-1072. PubMed ID: 28758825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
    Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
    Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.
    Williams ME; Bernstein SH; Jares P; Kahl BS; Witzig TE; Gordon LI
    Leuk Lymphoma; 2013 Sep; 54(9):1882-90. PubMed ID: 23363271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
    Jain P; Wang M
    Am J Hematol; 2019 Jun; 94(6):710-725. PubMed ID: 30963600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel agents in mantle cell lymphoma.
    Tucker D; Rule S
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):491-506. PubMed ID: 28480764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of B cell antigen receptors in mantle cell lymphoma.
    Fichtner M; Dreyling M; Binder M; Trepel M
    J Hematol Oncol; 2017 Oct; 10(1):164. PubMed ID: 29041946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in genomics and therapeutics in mantle cell lymphoma.
    Lu T; Zhang J; McCracken JM; Young KH
    Cancer Treat Rev; 2024 Jan; 122():102651. PubMed ID: 37976759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Linton K; Dreyling M
    Br J Haematol; 2021 Oct; 195(2):162-173. PubMed ID: 33783838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trials for frontline therapy of mantle cell lymphoma.
    Steiner RE; Romaguera J; Wang M
    J Hematol Oncol; 2018 Jan; 11(1):13. PubMed ID: 29374487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma in relapse: the role of emerging new drugs.
    Diefenbach CS; O'Connor OA
    Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic targets in mantle cell lymphoma.
    Martin P; Leonard JP
    Expert Opin Ther Targets; 2007 Jul; 11(7):929-40. PubMed ID: 17614761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma: insights into therapeutic targets at the preclinical level.
    Klener P
    Expert Opin Ther Targets; 2020 Oct; 24(10):1029-1045. PubMed ID: 32842810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.